App-Quantinova.ai

Safety and effectiveness of acute heart failure care as outpatient safe a meta analysis of studies comparing outpatient based management with standard inpatient care

Jameela Bahar - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

A retrospective observational study investigating hypertensive heart disease in an ethnically diverse south east london population

gabriel wisenfeld paine - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertensive heart disease

N/A

Progress and early outcomes of a cardiometabolic clinic in a uk tertiary cardiology centre

Rajay Narain - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Improving the assessment of iron status and replacement among heart failure patients

Hassan Yera - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Are patients with acute heart failure more likely to survive in cardiology wards because of selection bias

Shamshad Khan - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Heart failure burden of mental health and frailty correlation of efi nyha with phq 9 and gad scores

Anjali Patel - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Quantitative myocardial blood flow as a prognostic marker for cardiovascular outcomes in patients with type 2 diabetes mellitus a multicentre study

Noor Sharrack - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Type 2 diabetes mellitus

N/A

Automated deep learning quantification of epicardial adiposity on cardiac ct predicts atrial fibrillation risk immediately following cardiac surgery and long term

Henry West - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Fibrocalcific volume in aortic valve stenosis using contrast enhanced computed tomography

Shruti Joshi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

The rest and stress relationships between myocardial function blood flow and energetics in type 2 diabetes

Amrit Chowdhary - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Dobutamine

Cardiac and skeletal muscle energetic pathways following anthracycline chemotherapy for breast cancer

David Gamble - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Adenosine-5'-triphosphate

Measuring pcr atp as a marker of myocardial energetics across the spectrum of metabolic cardiac disease

John Aaron Henry - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Adenosine-5'-triphosphate

Can clinical examination and ecg predict a normal echocardiogram in patients presenting with palpitations a single centre experience

Mohamed Abouelasaad - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Structural Heart Disease

N/A

Masters athletes demonstrate sex differences in aortic stiffness

Rebecca Hughes - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arterial stiffness

N/A

Ct radiomics in carotid artery atherosclerosis a systematic evaluation of robustness reproducibility and predictive performance for culprit lesions

Elizabeth Le - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Body mass index associated differences in cardiac stress energetics in type 2 diabetes

Amrit Chowdhary - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

Dobutamine

Coexistent diabetes is associated with the presence of adverse phenotypic features in patients with hypertrophic cardiomyopathy

Nicholas Jex - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

A novel internally validated risk prediction model for adverse cardiac outcome in fabry disease

Christopher Orsborne - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Fabry disease

N/A

Cardiovascular magnetic resonance imaging in patients with clinical post covid 19 syndrome

Miroslawa Gorecka - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Manganese enhanced magnetic resonance imaging in type 1 and type 2 diabetes mellitus

Shruti Joshi - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Type 2 diabetes mellitus

N/A

Filters

45280 Abstracts